Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapybrachytherapyimage guided radiation therapy (IGRT)focused ultrasoundstereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018

July 13, 2018 — RaySearch has released RayCare 2A, the latest version of its flagship...

Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018

July 11, 2018 — Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG)...

MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018

July 5, 2018 — MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the...

Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018

Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of...

Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis

The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional...

Feature | Treatment Planning | July 03, 2018 | By Jeff Zagoudis

A new software developed and recently tested at the MD Anderson Cancer Center demonstrated the ability to largely...

Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018

July 2, 2018 — Researchers at The University of Kansas Cancer Center have launched a...

SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018

June 29, 2018 — In the battle against metastatic castrate-resistant...

Technology | Focused Ultrasound Therapy | June 19, 2018

June 19, 2018 — EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its...

Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018

June 18, 2018 — Elekta announced that its Elekta Unity...

Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018

June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., announced that Florida Hospital in...

Hitachi Medical Systems Europe Named Imaging Supplier for London Prostate Cancer Program
News | Prostate Cancer | June 14, 2018

June 14, 2018 — Hitachi Medical Systems Europe has been awarded the contract to supply six...

Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018

June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in...

PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018

June 13, 2018 — A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine...

Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018

June 12, 2018 — Recently published data from two new...

IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018

June 12, 2018 — IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner...

News | Brachytherapy Systems | June 07, 2018

June 7, 2018 — IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate...

he latest version of ASiR is being positioned for its ability to significantly reduce patient radiation dose during CT exams while achieving a reconstruction speed similar to that of conventional analytical reconstruction using filtered back projection.

Efficiency and patient comfort both factor into value-based imaging. But it was not the initial reason behind the development of iterative reconstruction. GE Healthcare originally planned to market Adaptive Statistical iterative Reconstruction (ASiR) as the means for improving image quality. The latest version of ASiR is being positioned for its ability to significantly reduce patient radiation dose during CT exams while achieving a reconstruction speed similar to that of conventional analytical reconstruction using filtered back projection. (Graphic from GE Healthcare Image Gallery)

Blog | Oncology Information Management Systems (OIMS) | June 05, 2018

What something does is more important than what it is. This is common knowledge in consumer electronics.

...

Overlay Init